This feed logs changes that ClinicalTrials.gov has recorded for the trials cited on PeptideBlog. It watches status, phase, enrollment, start and completion dates, whether results have been posted, and sponsor. The registry is checked twice a day, and an entry appears only when one of those fields actually changes, so a quiet stretch means no tracked trial was updated. For the full list of studies, see the clinical trial tracker.
Every trial on this site is re-checked against ClinicalTrials.gov at least every few days. When a status, phase, enrollment number, date, sponsor or results flag changes, it shows up here. Subscribe by RSS.
November 17, 2026
- Status: Not yet recruiting → Recruiting
Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) NCT07868835 - Status: Not yet recruiting → Recruiting
Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) NCT07868939
November 14, 2026
- Added to the tracker (Not yet recruiting)
A Study Assessing Eloralintide (LY3841136) in Healthy Participants NCT07935304
November 13, 2026
- Completion date: 2027-01-10 → 2026-12-01
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity NCT06745284 - Primary completion date: 2027-01-08 → 2026-11-01
A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity NCT06745284 - Status: Active not recruiting → Completed
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation NCT06299098
November 10, 2026
- Added to the tracker (Completed)
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight NCT06987513 - Results posted: No → Yes
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes NCT05936151
November 9, 2026
- Added to the tracker (Completed)
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight NCT06649045 - Added to the tracker (Completed)
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction NCT05371496 - Added to the tracker (Completed)
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes NCT01167881 - Added to the tracker (Completed)
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetes NCT00508287
November 7, 2026
- Start date: 2026-07-31 → 2026-09-04
UBT251 Injection Phase Ⅲ Study (Overweight or Obesity) NCT07648225 - Status: Not yet recruiting → Active not recruiting
UBT251 Injection Phase Ⅲ Study (Overweight or Obesity) NCT07648225 - Completion date: 2027-05-14 → 2027-04-08
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants NCT07626515 - Primary completion date: 2027-05-14 → 2027-04-08
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants NCT07626515 - Status: Recruiting → Active not recruiting
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants NCT07626515
November 5, 2026
- Added to the tracker (Recruiting)
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight NCT07720271 - Start date: 2026-09-18 → 2026-12-01
UBT251 Injection Phase Ⅲ Study (OSA-NPAP) NCT07767942
November 4, 2026
- Added to the tracker (Recruiting)
A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function NCT07519135 - Added to the tracker (Active not recruiting)
A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or Obesity NCT07508241 - Added to the tracker (Completed)
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity NCT07400679
November 1, 2026
- Added to the tracker (Not yet recruiting)
UBT251 Injection Phase Ⅲ Study (OSA-PAP) NCT07806851 - Added to the tracker (Recruiting)
Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity NCT07785934 - Added to the tracker (Not yet recruiting)
UBT251 Injection Phase Ⅲ Study (OSA-NPAP) NCT07767942 - Added to the tracker (Recruiting)
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight NCT07710768 - Added to the tracker (Recruiting)
A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant NCT07710729 - Added to the tracker (Recruiting)
A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) NCT07145151 - Added to the tracker (Recruiting)
UBT251 Injection Phase II Clinical Study (CKD) NCT07134335
October 30, 2026
- Added to the tracker (Active not recruiting)
Taldefgrobep Alfa in Adults With Overweight and Obesity NCT07281495 - Added to the tracker (Active not recruiting)
A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation NCT06299098 - Added to the tracker (Active not recruiting)
A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy NCT05337553 - Added to the tracker (Completed)
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia NCT01963598
October 29, 2026
- Added to the tracker (Not yet recruiting)
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk NCT07900633 - Added to the tracker (Not yet recruiting)
Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) NCT07868939 - Added to the tracker (Not yet recruiting)
Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) NCT07868835 - Added to the tracker (Active not recruiting)
VK2735 for Weight Management Phase 3 NCT07104500 - Added to the tracker (Completed)
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2) NCT06926842 - Added to the tracker (Completed)
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities NCT06662539
October 28, 2026
- Added to the tracker (Not yet recruiting)
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes NCT07881458 - Added to the tracker (Not yet recruiting)
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes NCT07881432 - Completion date: 2026-09-30 → 2026-10-02
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus NCT06628362 - Added to the tracker (Active not recruiting)
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) NCT06260722
October 27, 2026
- Added to the tracker (Not yet recruiting)
A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes NCT07890376 - Added to the tracker (Completed)
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes NCT06945419 - Added to the tracker (Recruiting)
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight NCT06143956
October 10, 2026
- Start date: 2026-09 → 2026-09-15
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight NCT07808060 - Status: Not yet recruiting → Recruiting
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight NCT07808060
October 9, 2026
- Added to the tracker (Recruiting)
Kisspeptin Administration Subcutaneously to Patients With IHH NCT05896293 - Added to the tracker (Completed)
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders NCT05633966 - Added to the tracker (Completed)
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism NCT04648969 - Added to the tracker (Terminated)
A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism NCT02369796 - Added to the tracker (Completed)
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling NCT01438073
October 8, 2026
- Added to the tracker (Completed)
Intratumoral Injections of LL37 for Melanoma NCT02225366 - Added to the tracker (Completed)
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight NCT05929079 - Added to the tracker (Completed)
TH9507 in Patients With HIV-Associated Lipodystrophy NCT00435136
October 7, 2026
- Completion date: 2026-09-24 → 2026-09-30
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus NCT06628362 - Status: Active not recruiting → Completed
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus NCT06628362